1. Home
  2. SSTI vs IBIO Comparison

SSTI vs IBIO Comparison

Compare SSTI & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SoundThinking Inc.

SSTI

SoundThinking Inc.

HOLD

Current Price

$6.44

Market Cap

85.3M

Sector

Technology

ML Signal

HOLD

Logo iBio Inc.

IBIO

iBio Inc.

HOLD

Current Price

$2.07

Market Cap

84.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSTI
IBIO
Founded
1996
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.3M
84.6M
IPO Year
2017
2009

Fundamental Metrics

Financial Performance
Metric
SSTI
IBIO
Price
$6.44
$2.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$15.00
$4.75
AVG Volume (30 Days)
176.6K
970.4K
Earning Date
03-03-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
73.08
EPS
N/A
N/A
Revenue
$34,753,000.00
N/A
Revenue This Year
$11.93
N/A
Revenue Next Year
$9.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
46.25
N/A
52 Week Low
$5.78
$0.56
52 Week High
$17.38
$4.86

Technical Indicators

Market Signals
Indicator
SSTI
IBIO
Relative Strength Index (RSI) 41.99 36.94
Support Level $6.03 $2.02
Resistance Level $7.96 $2.82
Average True Range (ATR) 0.51 0.23
MACD -0.07 -0.07
Stochastic Oscillator 17.65 9.70

Price Performance

Historical Comparison
SSTI
IBIO

About SSTI SoundThinking Inc.

SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Share on Social Networks: